MedCap

MedCap invests directly from its own balance sheet as a publicly listed company rather than managing a closed-end fund. Acquisitions are funded with corporate cash, debt, or equity issuance. The permanent-capital structure means there is no requirement to exit an investment after a set holding period, which suits the long regulatory and product-adoption timelines in life science.

The firm reports three operating segments: medical technology, specialty pharmaceuticals, and assistive devices. It seeks small and medium-sized businesses with established products, stable revenue, and a position in a defensible clinical niche. The model emphasizes operational improvement over financial engineering.

It functions as a hybrid. MedCap is the listed parent, but each subsidiary runs with its own management team and operational business plan. The parent sets strategic direction, allocates capital, and provides shared expertise, while the subsidiaries handle day-to-day commercial execution. This balances central oversight with local accountability.